AdventHealth Tampa logo
Guidelines
Relevant Studies

Relevant Studies

Relevant Studies

  • Sensitivity: 50%
  • Specificity: 80%
  • Positive Predictive Value: 12%
  • Negative Predictive Value: 97%
  • Sensitivity: 72.8%
  • Specificity: 86.4%
  • Positive Predictive Value: 16%
  • Negative Predictive Value: 98.9%
  • Sensitivity: 93.3%
  • Specificity: 95.2%
  • Positive Predictive Value: 93.3%
  • Negative Predictive Value: 95.2%
  • Sensitivity: 88%
  • Specificity: 90.1%
  • Positive Predictive Value: 35.4%
  • Negative Predictive Value: 99.2%
  • Sensitivity: 71.43%
  • Specificity: 84.25%
  • Positive Predictive Value: 30.3%
  • Negative Predictive Value: 97.6%
  • Published a trial of discontinuation of empiric vancomycin in patients with HCAP who had no respiratory cultures, but had negative MRSA PCR results
  • In-house mortality (7.7%) was not different than expected from previously published studies (10.7%)
  • The authors concluded that it is reasonable to discontinue empiric vancomycin HCAP therapy in patients with negative MRSA PCR studies